Skip to main content
TipRanks
Go Ultimate75% OFF

Lexington Biosciences (LXGTF) Financial Statements

8 Followers

Lexington Biosciences Financial Overview

Lexington Biosciences's market cap is currently C$212.24K. The company's EPS TTM is C$-0.01; its P/E ratio is -0.02; Lexington Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating IncomeC$ -158.00KC$ -173.48KC$ -312.63KC$ -459.50KC$ -533.53K
EBITDAC$ -168.00C$ 0.00C$ 0.00C$ 0.00C$ -1.15M
Net IncomeC$ -177.38KC$ -175.00C$ -324.24KC$ -480.00C$ -1.27M
Balance Sheet
Cash & Short-Term InvestmentsC$ 0.00C$ 0.00C$ 664.00C$ 27.64KC$ 12.82K
Total AssetsC$ 0.00C$ 0.00C$ 664.00C$ 27.64KC$ 12.82K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 843.48K
Net DebtC$ 0.00C$ 0.00C$ -664.00C$ -27.64KC$ 830.65K
Total LiabilitiesC$ 988.79KC$ 811.41KC$ 1.82MC$ 1.52MC$ 1.05M
Stockholders' EquityC$ -988.79KC$ -811.41KC$ -1.82MC$ -1.49MC$ -1.04M
Cash Flow
Free Cash FlowC$ 0.00C$ -664.00C$ -26.97KC$ -325.19KC$ -210.27K
Operating Cash FlowC$ 0.00C$ -664.00C$ -26.97KC$ -325.19KC$ -210.27K
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 340.00KC$ 115.77K

Currency in CAD

Lexington Biosciences Earnings and Revenue History

-3M-2M-1M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017201820192020202120222023RevenueEarningsProfit Margin

Lexington Biosciences Liabilities to Assets

0800K1.6M2.4M0 %100000 %200000 %300000 %LiabilitiesLiabilities to Assets2017201820192020202120222023AssetsLiabilitiesLiabilities to Assets

Lexington Biosciences Cash Flow

-2M-1M01M2M3M2017201820192020202120222023OperatingInvestingFinancing

Lexington Biosciences Forecast EPS vs Actual EPS

-0.200.30.50.811.3Q4 21EPS EstimateBeatMiss